1. Home
  2. ORGO vs BFK Comparison

ORGO vs BFK Comparison

Compare ORGO & BFK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORGO
  • BFK
  • Stock Information
  • Founded
  • ORGO 1985
  • BFK N/A
  • Country
  • ORGO United States
  • BFK United States
  • Employees
  • ORGO N/A
  • BFK N/A
  • Industry
  • ORGO Biotechnology: Pharmaceutical Preparations
  • BFK Finance Companies
  • Sector
  • ORGO Health Care
  • BFK Finance
  • Exchange
  • ORGO Nasdaq
  • BFK Nasdaq
  • Market Cap
  • ORGO 465.6M
  • BFK 417.9M
  • IPO Year
  • ORGO N/A
  • BFK N/A
  • Fundamental
  • Price
  • ORGO $4.32
  • BFK $9.52
  • Analyst Decision
  • ORGO Hold
  • BFK
  • Analyst Count
  • ORGO 1
  • BFK 0
  • Target Price
  • ORGO $6.00
  • BFK N/A
  • AVG Volume (30 Days)
  • ORGO 918.2K
  • BFK 117.1K
  • Earning Date
  • ORGO 08-07-2025
  • BFK 01-01-0001
  • Dividend Yield
  • ORGO N/A
  • BFK 4.33%
  • EPS Growth
  • ORGO N/A
  • BFK N/A
  • EPS
  • ORGO N/A
  • BFK N/A
  • Revenue
  • ORGO $458,760,000.00
  • BFK N/A
  • Revenue This Year
  • ORGO $1.10
  • BFK N/A
  • Revenue Next Year
  • ORGO $9.93
  • BFK N/A
  • P/E Ratio
  • ORGO N/A
  • BFK N/A
  • Revenue Growth
  • ORGO 5.35
  • BFK N/A
  • 52 Week Low
  • ORGO $2.28
  • BFK $8.55
  • 52 Week High
  • ORGO $6.71
  • BFK $10.48
  • Technical
  • Relative Strength Index (RSI)
  • ORGO 68.34
  • BFK 45.26
  • Support Level
  • ORGO $3.59
  • BFK $9.55
  • Resistance Level
  • ORGO $4.70
  • BFK $9.67
  • Average True Range (ATR)
  • ORGO 0.23
  • BFK 0.07
  • MACD
  • ORGO 0.12
  • BFK 0.00
  • Stochastic Oscillator
  • ORGO 81.15
  • BFK 28.57

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

About BFK BlackRock Municipal Income Trust

Blackrock Municipal Income Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from regular U.S. federal income tax.

Share on Social Networks: